The House
Markets Edge · Huang GoodmanVirginia Beach · Atlantic coast · since 1997
On the wire

Markets Edge

Issued Saturday, May 9, 2026 · 18:00 UTC Edition 8/day editions · 5 desks From the chopped neck
7
On the wire
$0.003per impression · vs Meta 0.007 CPM
8 monthsretention in hand · vs Meta 0.8 seconds
200brands you already own · Nike · YETI · Patagonia
Onenamed-account desk · by introduction
Ranked by the pour ISABELLA'S ISLAY HENRI IV MACALLAN 1926 LOUIS XIII PAPPY 23 JOHNNIE BLUE WELL POUR
Also crossing the wire
Showing 7 stories
ISABELLA'S ISLAY M&A Intelligence May 9, 2:01 PM EDT
Electronic Arts
FinancialContent ↗

Electronic Arts going private in $56.5B leveraged buyout

Gaming giant Electronic Arts is being taken private in a landmark $56.5 billion leveraged buyout, marking one of the largest gaming industry transactions.

ReadingPublic-market software and gaming valuations are repricing downward. Private equity sees a floor. The next six months will test whether they are right.
WatchFollow the debt structure. If syndication lags, leverage appetite has softened. The market will signal before the next announcement.
Read full analysis → Original ↗
m&aprivate equitylbogaming
HENRI IV Venture Intelligence May 9, 2:01 PM EDT
Cerebras Systems
TradingKey ↗

AI chip rival Cerebras targets largest US IPO of 2025

Cerebras Systems, a heavyweight AI chip designer competing with Nvidia, is planning to list next week in what could be the largest US IPO of 2025.

ReadingThe AI infrastructure IPO window is open. But it closes fast. Timing here is not coincidence—it is necessity.
WatchFirst-day trading velocity and lockup terms. If insiders sell early, conviction on the product was not as deep as the pitch deck suggested.
Read full analysis → Original ↗
aisemiconductoripoventure
MACALLAN 1926 Healthcare Intelligence May 9, 2:01 PM EDT
Odyssey Therapeutics
Renaissance Capital ↗

Autoimmune biotech Odyssey prices $225M IPO this week

Odyssey Therapeutics, a biotech focused on autoimmune diseases, has set terms for a $225 million IPO with pricing expected this week.

ReadingHealthcare IPOs are bifurcating by scientific clarity. Odyssey chose the narrow path. Investors are buying the precision, not the platform.
WatchPost-IPO lockup expiration in six months. Watch for insider selling patterns. They signal conviction on trial outcomes.
Read full analysis → Original ↗
biotechipoautoimmunehealthcare
LOUIS XIII Capital Markets May 9, 2:01 PM EDT
Suja Life
Stock Titan ↗

Cold-pressed juice maker Suja debuts on Nasdaq at $21 per share

Suja Life, a premium cold-pressed juice company, priced its IPO at $21 per share and debuted on Nasdaq, offering 8.9 million shares.

ReadingCold-pressed and plant-based beverages still attract institutional capital. The path is distribution, not innovation. Suja chose scale over story.
WatchQuarterly repeat purchase rates in the first earnings call. Retail velocity, not brand awareness, determines whether this IPO compounds or trades sideways.
Read full analysis → Original ↗
ipobeveragenutritioncapital markets
PAPPY 23 Venture Intelligence May 9, 2:01 PM EDT

Carlyle secures $5B for next buyout fund via LP liquidity financing

Carlyle has secured $5 billion for its next buyout fund through an innovative financing structure that also provides LP liquidity.

ReadingLarge PE funds are now financing their own closings. This signals confidence and impatience. Traditional LP fundraising is no longer the bottleneck.
WatchWhether other Tier 1 firms copy this structure within 90 days. If they do, it becomes standard. If not, Carlyle just found an information advantage.
Read full analysis → Original ↗
private equitycapital raisinglp liquidityfinancing
JOHNNIE BLUE M&A Intelligence May 9, 2:01 PM EDT
Private Equity Market
Reuters ↗

Large LBOs return as PE and sovereign wealth funds revive mega-deals

Private equity firms and sovereign wealth funds are reviving large leveraged buyouts, signaling renewed confidence in mega-deal financing and market conditions.

ReadingLeverage appetite has returned. The cost of capital is no longer the constraint. Deal sourcing is.
WatchDebt syndication speed on the next $10B+ LBO. If banks commit capital quickly, we have entered a new cycle. If they demand fees and risk retention, the window is closing.
Read full analysis → Original ↗
m&aprivate equitylboleverage
WELL POUR Venture Intelligence May 9, 2:01 PM EDT
HawkEye 360
Aviation Week ↗

Space intelligence provider HawkEye 360 leads IPO week; pricing details emerge

Space intelligence provider HawkEye 360 has detailed its initial IPO pricing plan and is leading a week with five IPO filings as the pipeline strengthens.

ReadingSpace tech IPO timing remains conditional on geopolitical positioning and government procurement clarity. HawkEye's pricing will signal whether those conditions have stabilized.
WatchFirst institutional demand signals after roadshow. If banks expand the range, conviction is real. If they hold or compress it, the market is still skeptical.
Read full analysis → Original ↗
ipospace techsatelliteintelligence
TUMIYETIPATAGONIATITLEISTCALLAWAYVINEYARD VINESCUTTER & BUCKCOLUMBIANIKEUNDER ARMOURNORTH FACECARHARTTSTANLEYHYDRO FLASKS'WELLMOLESKINELEATHERMANBOSEJBLAPPLE TUMIYETIPATAGONIATITLEISTCALLAWAYVINEYARD VINESCUTTER & BUCKCOLUMBIANIKEUNDER ARMOURNORTH FACECARHARTTSTANLEYHYDRO FLASKS'WELLMOLESKINELEATHERMANBOSEJBLAPPLE